DYAI
Dyadic International, Inc.
NASDAQ · USHealthcareBiotechnology
$1.21-3.97%
Price as of Jul 20, 2026
DYAI valuation
Dyadic International, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 5.17x
- P/S forward
- 6.57x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -108.14x
- Price / sales
- 14.82x
- Price / cash flow
- -7.71x
Enterprise value
- Enterprise value
- $42.6M
- EV / sales
- 14.33x
- EV / EBITDA
- -6.22x
- EV / EBIT
- -6.01x
- Market cap
- $44.1M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.